Search Results
Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.
Making an Impact Outside of Work
For Chris, volunteering for a cause Baxter also supports is motivating.
Giving Back Through Product Donations
Around the world, donated Baxter product provides humanitarian assistance, medical mission support and disaster relief.
Baxter to Expand Advanced Surgery Portfolio with Acquisition of Seprafilm Adhesion Barrier
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. The agreement is the latest example of Baxter's continued focus on acquiring products and technologies that have a strong strategic fit with the company's leading portfolio across the hospital, including in the operating room.
Baxter Receives NYSE Notice Regarding Delayed Form 10-Q Filing
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019. The indicated annual dividend rate is $0.88 per share of common stock. About Baxter
Proactively Managing Our Kidney Health for Better Outcomes
Being diagnosed with chronic kidney disease (CKD), the gradual loss of kidney function can be overwhelming; not knowing you have CKD can be life-threatening. The reality is that more than 30 million Americans have some stage of the disease.
Diverse Viewpoints Bring Success to the Business
'I have always believed that the strongest leaders allow everyone to have a voice at the table.'
Baxter and Ayogo Launch CKD&Me Patient Empowering Digital Education Tool at Kidney Week 2019
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Ayogo Health Inc., a behavioral science, digital health company, today announced the pilot of CKD&Me in several nephrology practices across the United States. Baxter and Ayogo partnered to build CKD&Me, a unique app for smartphones and tablets that tailors its educational content to chronic kidney disease (CKD) patients’ individual learning needs.